Annual report pursuant to Section 13 and 15(d)

Stockholders??? Deficit (Details Narrative)

v3.23.3
Stockholders’ Deficit (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Aug. 31, 2023
Jun. 30, 2023
Feb. 10, 2023
Sep. 30, 2022
Sep. 15, 2022
Aug. 15, 2022
Jun. 30, 2023
Aug. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Offering price for common stock                 $ 20,895,958 $ 1,908,693  
Net proceeds from issuance of common stock                 $ 21,006,371 1,841,918  
Stockholders' equity, reverse stock split 1-for -22 reverse stock split                    
Conversion of convertible securities                    
Preferred stock, shares issued       0         0 0  
Preferred stock, shares outstanding       0         0 0  
Warrant expirations                 332    
Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Offering price for common stock                 $ 83 $ 3  
Sale of common stock, net of issuance costs, shares                 833,287 30,206  
Number of convertible shares                   25,101  
Conversion of convertible securities                   $ 3  
Shares issued upon vesting                   1,087  
Net share settlement of warrants, shares                 519,492    
Prefunded Warrant [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of common stock, net of issuance costs, shares                 137,998    
Warrants exercised                 137,999    
Common Stock Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of common stock, net of issuance costs, shares                 519,492    
Net share settlement of warrants, shares                 1,014,872    
Chardan Capital Markets LLC [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of common stock, net of issuance costs, shares   166,363                  
Warrants to purchase shares   227,272         227,272        
Exercisable price   $ 9.90         $ 9.90        
Net proceeds from issuance of private placement   $ 1,900,000         $ 2,300,000        
2022 Sales Agreement [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Offering price for common stock           $ 7,800,000          
Gross proceeds from sale agreement     $ 15,000,000.0                
Net proceeds from issuance of common stock     $ 13,600,000                
2022 Sales Agreement [Member] | Underwriter Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants to purchase shares     44,190           6,818    
Exercisable price     $ 29.70                
2022 Sales Agreement [Member] | Underwriter Warrants [Member] | Forecast [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercisable price                     $ 14.8478
2022 Sales Agreement [Member] | Common Stock [Member] | Investors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of common stock, net of issuance costs, shares     530,222                
2022 Sales Agreement [Member] | Prefunded Warrant [Member] | Investors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants to purchase shares     101,090                
Exercisable price     $ 0.0022                
Warrants issue price per share     $ 23.7578                
2022 Sales Agreement [Member] | Prefunded Warrant [Member] | Chardan Capital Markets LLC [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants to purchase shares   60,909         60,909        
2022 Sales Agreement [Member] | Common Warrant [Member] | Investors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants to purchase shares     1,262,618                
Exercisable price     $ 23.76                
2022 Sales Agreement [Member] | Common Warrant [Member] | Chardan Capital Markets LLC [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercisable price                 $ 0.0022    
2022 Sales Agreement [Member] | Common Warrant [Member] | Chardan Capital Markets LLC [Member] | Forecast [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercisable price                     $ 14.8478
2022 Sales Agreement [Member] | BTIG, LLC [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Offering price for common stock           $ 25,000,000.0          
Sale of stock, number of shares issued                 136,702    
Gross proceeds from sale agreement                 $ 5,700,000    
Net proceeds from issuance of common stock                 $ 5,500,000    
Securities Purchase Agreement [Member] | Accredited Investors [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stockholders' equity, reverse stock split         1-for-14 reverse stock split            
Securities Purchase Agreement [Member] | Accredited Investors [Member] | Series 3 Convertible Preferred Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of stock, number of shares issued               22,275      
Preferred stock, par value               $ 100      
Conversion of convertible securities       $ 25,101              
Securities Purchase Agreement [Member] | Accredited Investors [Member] | Series 4 Convertible Preferred Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of stock, number of shares issued               225      
Preferred stock, par value               $ 100      
Number of convertible shares               251      
Equity instrument conversion price               $ 89.628      
Voting rights per share               each share of Series 4 Convertible Preferred Stock was entitled to 811,688 votes per share      
Conversion of convertible securities       $ 25,101              
Securities Purchase Agreement [Member] | Accredited Investors [Member] | Series 3 Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants to purchase shares               12,548      
Net proceeds from issuance of private placement               $ 2,100,000      
Gross proceeds from issuance of private placement               $ 2,300,000      
Number of convertible shares               24,850      
Equity instrument conversion price               $ 89.628      
Securities Purchase Agreement [Member] | Accredited Investors [Member] | Series 3 Warrants [Member] | Private Placement [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance costs               $ 100,000      
2022 Sales Ageement [Member] | BTIG [Member] | Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Sale of stock, number of shares issued                   30,206  
Net proceeds from issuance of common stock                   $ 1,900,000  
Gross proceeds from issuance of common stock                   $ 2,000,000.0